Focus type: function_assignment · Hypothesis slug: function-hypothesis-go-0034727
Source: genes/human/ATG2A/ATG2A-ai-review.yaml (free-text)
Seed: Human ATG2A participates in piecemeal microautophagy of the nucleus (GO:0034727), inherited via PANTHER node PTN000324023 from yeast ATG2.
Verdict: Over-annotated / refuted as a direct, applicable function assignment. The annotation of human ATG2A with GO:0034727 "piecemeal microautophagy of the nucleus" (PMN) is an IBA-only phylogenetic carry-over from budding yeast and should be treated as non-core and a candidate for removal in the ATG2A curated review. The human ATG2A GO:0034727 record carries evidence code IBA, assignedBy=GO_Central, reference=GO_REF:0000033 (PAINT phylogenetic annotation), and withFrom=PANTHER:PTN000324023 plus the yeast ATG2 gene (SGD:S000005186). That is precisely the phylogenetic propagation the seed hypothesis flagged. There is no experimental (IDA/IMP/IGI/EXP) support for PMN in human ATG2A, or in any metazoan.
The seed asked a sharp question: does ATG2A's lipid-transfer/membrane-tethering machinery participate in this specific microautophagic route in mammals, and is any absence a demonstrated lineage restriction or merely a gap in target experiments? The evidence points firmly to a demonstrated lineage restriction. PMN is a fungal-specific process defined at the nucleus–vacuole (NV) junction, which is built by the direct Nvj1–Vac8 interaction and requires a vacuole. QuickGO shows that all 44 experimental-evidence PMN annotations are in Saccharomyces cerevisiae (100%). PANTHER v19 (positive-control validated by yeast ATG2 → human ATG2A/ATG2B) shows that NVJ1 and VAC8 have no human ortholog, while ATG2 is conserved. Because the scaffolds that make PMN a distinct microautophagic route are absent from the human lineage, the term cannot biologically apply to human ATG2A — regardless of the fact that ATG2's own lipid-supply subunit is conserved.
Human ATG2A's genuine, experimentally supported function is macroautophagic lipid transfer and membrane tethering at ER–phagophore contact sites. Every direct-evidence GO annotation on Q2TAZ0 describes macroautophagy. The only mammalian nuclear-degradation events that are actually documented (lamin B1/LMNB1, SIRT1 turnover) are LC3-dependent macroautophagic nucleophagy — a different process and GO term from microautophagic PMN, and one whose dependence on ATG2A is itself untested. The recommended curation lead is therefore: mark GO:0034727 non-core / remove, retain the macroautophagy lipid-transfer core, and do not substitute a nucleophagy term without independent experimental support.
UniProt Q2TAZ0 (ATG2A, Homo sapiens) carries 17 GO cross-references. Every experimental / direct-evidence annotation describes macroautophagy, not microautophagy of the nucleus:
By contrast, GO:0034727 (PMN) is annotated only as IBA:GO_Central — phylogenetic inference. It sits in a cluster of selective-autophagy process terms (pexophagy, reticulophagy, glycophagy, mitophagy) that are all inherited by ancestry with no human experimental support. These are generic consequences of ATG2A being core autophagy machinery, not evidence of a demonstrated PMN role.
The core molecular activity is established directly. In PMID: 31271352, The autophagic membrane tether ATG2A transfers lipids between membranes, the authors "demonstrate that human ATG2A is a lipid transfer protein. ATG2A can extract lipids from membrane vesicles and unload them to other vesicles," acting most efficiently when it tethers two membranes; recruitment is via the PI3P effectors WIPI4/WIPI1. PMID: 33850023 frames ATG2 as the protein "proposed to transfer bulk lipid from the endoplasmic reticulum (ER) during autophagosome biogenesis" — i.e., ER-to-phagophore bulk lipid transfer during macroautophagy, with no requirement that ATG2 recognize nuclear cargo. This is reinforced by PMID: 38622126, which shows ANKFY1 recruits ATG2A to PI3P-enriched endosomes to donate lipid to phagophores, again a macroautophagy function.
Interpretation. ATG2A's core, experimentally supported function is a lipid-transfer/membrane-tether activity feeding phagophore expansion in macroautophagy. PMN is not part of this experimentally supported core in humans.
QuickGO reports 59,856 total annotations for GO:0034727, but restricting to experimental evidence (ECO:0000269 EXP and descendants) leaves 44 annotations, all in S. cerevisiae (taxon 559292; 100%). The experimentally annotated PMN gene set is a fungal cast: yeast ATG2 plus NVJ1, VAC8, OSH1–7, the core ATG1–18 machinery, and vacuolar fusion genes (VAM3/6/7, VPS41, YPT7). All non-yeast PMN annotations — including human ATG2A — are IEA/IBA only.
Mechanistically, PMN is degradation of the nucleus by microautophagy at NV junctions formed by the direct Nvj1 (perinuclear ER)–Vac8 (vacuole) interaction. PMID: 18701704 states that "Piecemeal microautophagy of the nucleus (PMN) occurs in Saccharomyces cerevisiae at nucleus-vacuole (NV) junctions and results in the pinching-off and release into the vacuole of nonessential portions of the nucleus." PMID: 28533415 shows that "Disruption of the Nvj1p-Vac8p interaction results in the loss of tight NVJs, which impairs piecemeal microautophagy of the nucleus" — the route is strictly junction-dependent. PMID: 20943953 further shows PMN requires the vacuolar V-ATPase electrochemical gradient and Osh1p, and forms a vacuolar diffusion barrier — all fungal features.
Mammals have no vacuole and no Nvj1/Vac8 orthologs (Finding F003), so the specific microautophagic route named by GO:0034727 cannot occur in human cells. The mammalian nuclear-degradation events that are documented are macroautophagic (LC3-dependent): PMID: 33292048 identifies "the nuclear lamina protein LMNB1 (lamin B1) as a nuclear autophagy substrate in primary human cells," and describes SIRT1 as a nuclear autophagy substrate — a process mechanistically distinct from yeast microautophagic PMN.
Interpretation. GO:0034727 is a yeast-specific term at the experimental level. Its cross-species propagation onto human ATG2A conflates a fungal microautophagic route with the (mechanistically unrelated) mammalian macroautophagic nucleophagy.
The single human ATG2A (UniProtKB:Q2TAZ0) GO:0034727 annotation is evidence=IBA, assignedBy=GO_Central, reference=GO_REF:0000033 (PAINT), withFrom=PANTHER:PTN000324023 and SGD:S000005186 (yeast ATG2) — pure phylogenetic propagation from yeast ATG2, exactly as the seed hypothesis anticipated.
An orthology test was run against the PANTHER v19 ortholog API (yeast taxon 559292 → human 9606), validated with a positive control:
| Query protein (yeast) | UniProt | Human ortholog returned? | Result |
|---|---|---|---|
| ATG2 (positive control) | P53855 | Yes — ATG2A (Q2TAZ0, least-diverged), ATG2B (Q96BY7) | Conserved |
| NVJ1 (NV-junction ER protein) | P38881 | None | No human ortholog |
| VAC8 (NV-junction vacuolar protein) | P39968 | None | No human ortholog |
(An initial NVJ1 lookup mistakenly used P32602, which is actually SEC17/α-SNAP; this was corrected to the verified NVJ1 accession P38881. All accessions were checked in UniProt.)
The two proteins that define the PMN NV junction have no human ortholog, while ATG2 itself is well conserved. Combined with F002, this resolves the seed's central question — "demonstrated lineage restriction or loss vs. absence of target experiments" — decisively toward demonstrated lineage restriction: the scaffold that makes PMN a distinct microautophagic route is absent from the human lineage.
Interpretation. ATG2 conservation is real, but it does not carry the PMN process with it, because PMN is defined by junction machinery (Nvj1/Vac8) and an organelle (the vacuole) that mammals lack. Propagating GO:0034727 to ATG2A on the strength of ATG2 orthology alone is a category error.
The core issue is that ATG2 conservation ≠ PMN conservation. ATG2 is a shuttle/tether that supplies lipid to a growing membrane; the identity of the degradative route is set by other, non-conserved components.
YEAST (S. cerevisiae) HUMAN (H. sapiens)
--------------------- ------------------
Perinuclear ER ── Nvj1 ─┐ ER ──────────────┐
│ NV junction (no Nvj1) │
Vacuole ──────── Vac8 ─┘ (Velcro) (NO VACUOLE) │
│ │
│ PMN = MICROautophagy │
▼ nucleus pinched into vacuole ▼
GO:0034727 (experimental, 44/44 = yeast) Macroautophagy: phagophore
Requires: vacuole + Nvj1–Vac8 + ATG core expansion via ATG2A lipid transfer
from ER (WIPI4/WIPI1, PI3P)
ATG2 ── conserved ──────────────────► ATG2A / ATG2B
Nvj1 ── NO human ortholog ──────────► (absent)
Vac8 ── NO human ortholog ──────────► (absent)
Mammalian nuclear degradation that IS documented:
LMNB1 (lamin B1), SIRT1 turnover → LC3-dependent MACROautophagic nucleophagy
(a DIFFERENT GO term than microautophagic PMN)
Where ATG2A actually acts (human, experimentally supported):
| Layer | Term | Evidence | Process |
|---|---|---|---|
| Molecular function | GO:0120013 lipid transfer activity | IDA | Macroautophagy |
| Cellular component | GO:0005789 ER membrane; GO:0034045 phagophore assembly site membrane; GO:0044232 organelle MCS | EXP/IDA | Macroautophagy |
| Biological process | GO:0000045 autophagosome assembly; GO:2000786 positive regulation of autophagosome assembly | IMP/IDA | Macroautophagy |
| Biological process | GO:0034727 PMN | IBA only | fungal microautophagy — not applicable |
Even granting the seed's fair point that "lipid-supply participation does not require ATG2A to recognize nuclear cargo directly," the route still requires an NV junction and a vacuole to be PMN. Absent those, any ATG2A lipid-transfer contribution to a mammalian nuclear-degradation event would be captured by macroautophagy/nucleophagy terms, not by GO:0034727.
| Citation | Evidence type | Supports/Refutes/Qualifies/Competing | Claim tested | Key finding | Context | Confidence & limitations |
|---|---|---|---|---|---|---|
| PMID: 31271352 | Direct in vitro assay | Refutes (redirects to macroautophagy) | ATG2A's core molecular function | Human ATG2A extracts/transfers lipids between vesicles; tether-enhanced; WIPI4/WIPI1-recruited | Recombinant human ATG2A + liposomes | High; in vitro only |
| PMID: 33850023 | Model/review | Qualifies | ATG2 role is bulk ER→phagophore lipid transfer | Positions ATG2 in macroautophagy lipid supply with scramblases (TMEM41B/VMP1/ATG9) | Conceptual/biochemical | Review-level orientation |
| PMID: 38622126 | Direct/interaction/mutant | Supports (macroautophagy) | ATG2A lipid-source flexibility | ANKFY1 recruits ATG2A to PI3P endosomes; ATG2A/B depletion impairs autophagosome growth | Human cells | High; unrelated to PMN |
| PMID: 18701704 | Mutant/morphological | Refutes (defines PMN as yeast-specific) | Where PMN occurs | PMN occurs in S. cerevisiae at NV junctions; requires core ATG genes | S. cerevisiae | High; organism-specific by design |
| PMID: 28533415 | Structural + mutant | Refutes | PMN depends on Nvj1–Vac8 junction | Disrupting Nvj1p–Vac8p abolishes tight NVJs and impairs PMN | S. cerevisiae | High; machinery absent in mammals |
| PMID: 20943953 | Mechanistic/imaging | Refutes | PMN vesicle formation requirements | NV junctions need Nvj1p/Vac8p, V-ATPase gradient, Osh1p; form vacuolar diffusion barrier | S. cerevisiae | High; strongly fungal |
| PMID: 19182523 | Morphological (EM) | Refutes | PMN genetics/morphology | PMN ("micronucleophagy") requires core ATG genes at NV junctions | S. cerevisiae | High |
| PMID: 15367582 | Interaction/localization | Refutes | PMN cofactors | Osh1p targeted to NV junctions via Nvj1p; Osh1–7 needed for PMN vesicles | S. cerevisiae | High |
| PMID: 15958487 | Mutant | Refutes | PMN lipid requirements | VLCFA/Tsc13p at NV junctions shape PMN vesicle biogenesis | S. cerevisiae | High |
| PMID: 31512555 | Structural/biophysical | Refutes | Vac8 governs PMN vs Cvt | Vac8 quaternary states differentially regulate PMN and Cvt | S. cerevisiae | High; Vac8 absent in humans |
| PMID: 33292048 | Localization/substrate | Competing (alternative route) | Mammalian nuclear autophagy mechanism | LMNB1 and SIRT1 are substrates of LC3-dependent (macro)nuclear autophagy | Primary human cells | High; supports macroautophagic, not micro-PMN |
| PMID: 38308641 | Mechanistic | Competing (alternative route) | Mammalian nucleophagy mechanism | SUMOylated Lamin B1 binds LC3 → lysosomal delivery (macroautophagic nucleophagy) | Rodent/human neurons | Moderate; not ATG2A-specific |
| UniProt Q2TAZ0 / QuickGO annotation | Database | Refutes | Evidence basis of human PMN annotation | Human ATG2A GO:0034727 = IBA, GO_REF:0000033, withFrom PANTHER:PTN000324023 + yeast ATG2 | Database | High; direct record |
| QuickGO experimental filter | Database/computational | Refutes | Species distribution of PMN experiments | 44/44 experimental GO:0034727 annotations are S. cerevisiae | Database | High |
| PANTHER v19 ortholog API | Computational/evolutionary | Refutes | Conservation of PMN machinery | NVJ1, VAC8 → no human ortholog; ATG2 → ATG2A/B (positive control) | Computational | High; single-method — see limitations |
| GO ID | Term | Aspect | On ATG2A now | Lead action |
|---|---|---|---|---|
| GO:0034727 | piecemeal microautophagy of the nucleus | BP | IBA:GO_Central | REMOVE / treat as non-core — over-propagated, lineage-restricted (fungal) term |
| GO:0044804 | autophagy of nucleus (nucleophagy) | BP | absent | Do not add without evidence (mammalian nucleophagy is macroautophagic; ATG2A role untested) |
| GO:0120013 | lipid transfer activity | MF | IDA | RETAIN — core MF |
| GO:0000045 | autophagosome assembly | BP | IMP | RETAIN — core BP |
| GO:2000786 | positive regulation of autophagosome assembly | BP | IDA | RETAIN |
| GO:0034045 | phagophore assembly site membrane | CC | EXP | RETAIN — core CC |
| GO:0005789 | endoplasmic reticulum membrane | CC | EXP | RETAIN |
| GO:0044232 | organelle membrane contact site | CC | IDA | RETAIN |
Rationale. The experimentally supported core of ATG2A is a lipid-transfer / membrane-tether MF acting at ER–phagophore contact sites in macroautophagy. GO:0034727 is one of several IBA selective-autophagy process terms inherited by ancestry; for a fungal-specific microautophagic route absent from the human cell, the term is best treated as not supported / non-core. We deliberately avoid recommending "protein binding" (GO:0005515) as a substitute; the informative core is the lipid-transfer MF and the macroautophagy CC/BP set, which are already present.
Separating the layers: the immediate molecular function (lipid transfer) is well supported and macroautophagic; PMN is a cellular-route claim that fails on machinery-conservation grounds; mammalian nucleophagy is a distinct competing route that would map to a different term.
withFrom PANTHER:PTN000324023 + SGD:S000005186 (yeast ATG2) — confirmed by QuickGO, exactly matching the seed. This is legitimate automated inference being tested for biological applicability.Human ATG2A's demonstrated function is macroautophagic lipid transfer/membrane tethering at ER–phagophore contact sites. GO:0034727 (piecemeal microautophagy of the nucleus) is a yeast-specific microautophagic process propagated to ATG2A by phylogeny only (IBA/PAINT, PANTHER:PTN000324023 + yeast ATG2); the defining machinery — a vacuole and the Nvj1–Vac8 junction — is absent in mammals (NVJ1/VAC8 have no human ortholog), a demonstrated lineage restriction rather than an untested cargo. Recommend treating GO:0034727 as over-annotated / non-core for human ATG2A (candidate for removal), while noting that a generic macroautophagic-nucleophagy role remains untested and must not be annotated without direct evidence.